Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes

This study has been completed.
Information provided by (Responsible Party):
Sanofi Identifier:
First received: September 27, 2013
Last updated: April 8, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)